跳至主要内容
临床试验/NCT01113294
NCT01113294Unknown4 期

Catheter Ablation for Atrial Fibrillation: A Multicenter Clinical Trial

Wuhan University1 个研究点 分布在 1 个国家目标入组 2,040 人开始时间: 2009年1月1日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
2,040
试验地点
1
主要终点
recurrence of atrial arrhythmias (AF, AFL, AT)

研究概览

简要总结

To compare the efficacy of different procedures, identify the optimal procedure, ablation sites, ablation endpoints and post-operative anticoagulation strategy, establish the optimal treatment strategy for atrial fibrillation.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Atrial fibrillation recorded by ECG or Holter;
  • Age: 18 ~ 75 years;
  • Patients who are willing to enroll in the trial

排除标准

  • Patients accompanied hyperthyroidism;
  • Patients with sever liver or renal dysfunction;
  • Patients with sever cardiac dysfunction;
  • Patients had previous radiofrequency catheter ablation in the LA or Maze surgical procedure;
  • Patients with emboli in atrium;
  • Pregnant woman

结局指标

主要结局

recurrence of atrial arrhythmias (AF, AFL, AT)

时间窗: 12 month

次要结局

  • Number of participants with all-cause death(12 month)
  • severe blooding complications(12 month)
  • cardio-cerebrovascular complications(12 month)
  • Number of participants with cardiovascular death events(12 month)

研究者

发起方
Wuhan University
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Efficacy and Safety Study of Catheter Ablation for... | 临床试验